Elizabeth Blackburn, PhD, AC, FRS, FAA, FRSNPresident, The Salk Institute
Dr. Elizabeth Blackburn won the Nobel Prize in Physiology or Medicine in 2009 for discovering the molecular nature of telomeres, the ends of chromosomes that serve as protective caps essential for preserving genetic information, and for co-discovering telomerase, an enzyme that maintains telomere ends. Both telomeres and telomerase are thought to play central roles in aging and diseases such as cancer, and her work helped launch entire new fields of research in these areas.
Elizabeth Blackburn, PhD, AC, FRS, FAA, FRSNPresident, The Salk InstituteBio
Mark BritnellChairman & Partner, Global Health Practice at KPMG
Dr. Mark Britnell is Chairman and Partner of the Global Health Practice at KPMG. Since 2009, he has worked in 60 countries, helping governments, public and private sector organizations with operations, strategy and policy. He has a pioneering and inspiring global vision for healthcare in both the developed and developing world and has written extensively on what works around the world. As Chairman for the Global Healthcare Practice, Mark has responsibility for KPMG’s 4,000 health staff across more than 40 countries. Mark has dedicated his professional life to healthcare and has led organizations at local, regional, national and global levels.
Mark BritnellChairman & Partner, Global Health Practice at KPMGBio
David Calabrese, RPh, MHPVice President and Chief Pharmacy Officer, OptumRx
David Calabrese currently serves as vice president, chief pharmacy officer (CPO) for OptumRx. In this capacity, his primary responsibilities include executive level oversight and strategic accountability for several of the organization’s clinical programs and services, including Clinical Account Management, Pharmacy and Therapeutics (P&T) Committee functions and Clinical Quality Management. Prior to his current position, he served as the CPO of Catamaran, one of the nation’s largest pharmacy benefit management (PBM) companies serving 35 million lives, which combined with OptumRx in 2015. Before joining Catamaran, David served as chief clinical officer at MedMetrics Health Partners, a small regionally-based PBM, held managed care clinical pharmacy leadership roles at Harvard Pilgrim Health Care and with CareGroup, an integrated health care system.
David Calabrese, RPh, MHPVice President and Chief Pharmacy Officer, OptumRxBio
August W. Calhoun, PhDSenior Vice President of North America Services, Siemens Healthineers
August Calhoun, PhD, is Senior Vice President of North America Services at Siemens Healthineers. In this role, he is responsible for all Services business lines in the U.S., including Customer Services (preventative maintenance and repair for imaging and laboratory diagnostic equipment, and education and training), Enterprise Services (advisory services, multi-vendor management, asset management and other enterprise services offerings) and Digital Services (workflow, data and analytics software and services). Calhoun is based at the U.S. Services headquarters in Cary, N.C., USA.
Before joining Siemens Healthineers in 2016, Calhoun was Senior Vice President and General Manager of Provider Solutions at Truven Health Analytics, a cloud-based healthcare data and analytics firm in Ann Arbor, Mich. In this role, he oversaw global sales, marketing, services, consulting, operations and product management, providing products and services that leveraged data and analytics to guide business leaders and clinicians.
Prior to his tenure at Truven, Calhoun spent six years with Dell, Inc., most recently as Vice President and General Manager of the company’s Healthcare and Life Sciences Industry. He began his healthcare career at IBM and held leadership positions in IBM Global Services, Business Consulting Services, and sales, eventually rising to the position of Executive Director of IBM’s Pharmaceutical Industry.
Calhoun holds a doctorate in Physical Chemistry from the University of Pennsylvania in Philadelphia and a bachelor’s degree in Chemistry from the University of Delaware in Newark.
Calhoun focuses on spending time with his family when not working. His leisure activities include volunteering and coaching with his community’s soccer club, fitness and wellness, and he is an avid reader.
August W. Calhoun, PhDSenior Vice President of North America Services, Siemens HealthineersBio
Robert M. Califf, MD, MACCVice Chancellor for Health and Data, Center for Integrated Health Data Science at Duke University: Former Commissioner, U.S. Food & Drug Administration
Robert M. Califf, MD, MACC, is vice chancellor for health data science and director of the Center for Integrated Health Data Science at Duke Health, the Donald F. Fortin, MD Professor of Cardiology in the Duke University School of Medicine, and an advisor for Verily Life Sciences, a member of the Alphabet family of companies formed by Google. He served in the administration of President Barack Obama as Deputy Commissioner for Medical Products and Tobacco in the U.S. Food and Drug Administration (FDA) from 2015-106, and as Commissioner of Food and Drugs from 2016-2017.
Robert M. Califf, MD, MACCVice Chancellor for Health and Data, Center for Integrated Health Data Science at Duke University: Former Commissioner, U.S. Food & Drug AdministrationBio
Richard Carmona, MD, MPH, FACS17th Surgeon General of the United States; Chief of Health Innovations, Canyon Ranch, Distinguished Professor, University of Arizona
Richard Carmona was the 17th Surgeon General of the United States. He is currently Chief of Health Innovations at Canyon Ranch and Distinguished Professor at both the University of Arizona and Ohio State University. He serves on several corporate boards and works with private equity and venture capital firms to identify emerging science and technology to translate to market for economic and public benefit.
Richard Carmona, MD, MPH, FACS17th Surgeon General of the United States; Chief of Health Innovations, Canyon Ranch, Distinguished Professor, University of ArizonaBio
Deepak Chopra, MD, FACPFounder, The Chopra Center for Wellbeing
Deepak Chopra, founder of The Chopra Foundation and co-founder of The Chopra Center for Wellbeing is a world-renowned pioneer in integrative medicine and personal transformation, and is Board Certified in Internal Medicine, Endocrinology and Metabolism. He is a Fellow of the American College of Physicians, a member of the American Association of Clinical Endocrinologists and Clinical Professor in the Department of Family Medicine and Public Health at the University of California, San Diego, Health Sciences. TIME magazine has described him as "one of the top 100 heroes and icons of the century.”
Deepak Chopra, MD, FACPFounder, The Chopra Center for WellbeingBio
Christopher Coburn, MBAChief Innovation Officer, Partners HealthCare System & President of Partners HealthCare International
Chris Coburn is Chief Innovation Officer, Partners HealthCare System and President of Partners HealthCare International. Partners is the largest academic research enterprise in the United States with $12 billion in revenue, more than 1.5 million patients and over $1.6 billion in annual research expenditures. Mr. Coburn leads a team of more than 110 tasked with the worldwide commercial application of the unique capabilities and discoveries of Partners’ faculty and its 73,000 employees. Prior to joining Partners, Mr. Coburn was the founding director of Cleveland Clinic Innovations and served for 13 years as its executive leader.
Christopher Coburn, MBAChief Innovation Officer, Partners HealthCare System & President of Partners HealthCare InternationalBio
Craig CogutChairman and President, Pegasus Capital
Mr. Cogut has spent a career building successful investment businesses. He founded Pegasus Capital Advisors in 1996 and serves as its Chairman and President. Through Mr. Cogut’s leadership, Pegasus has focused increasingly on areas influenced by global resource scarcity and the need for resource efficiency, as well as on the growth in demands for human wellness. In 1990, Mr. Cogut co-founded and was one of the original partners at Apollo Advisors L.P., a position he held for five years preceding the creation of Pegasus.
An active philanthropist in the fields of improving education, building civil society and championing environmental and health issues, Mr. Cogut helped establish The Cogut Center for the Humanities at Brown University where he also served as trustee for several terms. In 2011, Mr. Cogut co-founded The Polyphony Foundation, an organization created to provide equal opportunity music education for Arab and Jewish Israeli youth, where he currently serves as its Chairman. In addition, he serves as a board member for The McCain Institute for International Leadership at Arizona State University, for the R-20 Regions of Climate Action, for Six Senses (a luxury hotel and resort chain focused on sustainability and wellness), for Lighting Science Group (an LED company focused on using science to improve the health of humans on the planet), for PanTheryx (a medical nutrition company whose primary product, DiaResQ, was chosen by The Innovation Countdown 2030 as one of the top 30 lifesaving innovations with great promise to transform global health by 2030) and as a board member emeritus for the Arizona State University’s Global Institute of Sustainability. Mr. Cogut is an alumnus of Brown University and Harvard Law School.
Craig CogutChairman and President, Pegasus CapitalBio
Toby Cosgrove, MDCEO & President, Cleveland Clinic
Toby Cosgrove is CEO and President of Cleveland Clinic. He heads an $8 billion healthcare system including a main campus, 10 regional hospitals, 18 family health and surgery centers, and hospitals and clinics in Florida, Nevada, Toronto, Abu Dhabi and London (opening 2020). Under his leadership, Cleveland Clinic has become the No. 2 ranked hospital in America (U.S. News & World Report). He is a member of the National Academy of Medicine, and a Fellow of the National Academy of Inventors. In 2016, he was a Fortune Businessperson of the Year (No. 14). Three successive presidents of the United States have consulted him on healthcare issues.
Toby Cosgrove, MDCEO & President, Cleveland ClinicBio
Deborah DiSanzoGeneral Manager, IBM Watson Health
Deborah DiSanzo is the global General Manager for IBM Watson Health, the business unit founded to achieve IBMs next ‘moonshot’: to advance health at a global scale. Deborah leads a team of almost 7,000 employees around the world, ranging from medical experts to health economists to data scientists, UX experts and developers. Under her leadership, Watson Health has secured relationships with top collaborators, partners and clients across healthcare and life sciences. Deborah has a distinguished career working at the intersection of healthcare and technology. Prior to joining IBM, she was CEO of Philips Healthcare. Previously, she held management roles at Hewlett-Packard and Apollo Computer.
Deborah DiSanzoGeneral Manager, IBM Watson HealthBio
Daniel DoctoroffCEO, Sidewalk Labs
Daniel L. Doctoroff is CEO of Sidewalk Labs, an urban innovation company he launched with Google to improve cities for residents, businesses and city governments. Prior to founding Sidewalk, he was president and CEO of Bloomberg L.P. Dan previously served as deputy mayor for economic development and rebuilding for the City of New York. With Mayor Michael R. Bloomberg, Dan led the city’s dramatic economic resurgence, spearheading the effort to reverse New York’s fiscal crisis after 9/11 through a five-borough economic development strategy, including the creation of PlaNYC.
Daniel DoctoroffCEO, Sidewalk LabsBio
Murali Doraiswamy, MBBSProfessor, Duke Health and Member, Duke Institute for Brain Sciences
Dr. Doraiswamy is a doctor and brain scientist at Duke University Health System where he directs a leading clinical trials unit focused on Alzheimer’s disease prevention. He also serves as an advisor to many government agencies, advocacy groups and businesses, and is a member of the World Economic Forum’s Future Councils. He is the brain health advisor for Men’s Health magazine and AARP Magazine, and is the co-author of a popular book, The Alzheimer’s Action Plan.
Murali Doraiswamy, MBBSProfessor, Duke Health and Member, Duke Institute for Brain SciencesBio
A.J. DrexlerCEO & Chief Strategist, Campos
A.J. Drexler is the CEO and Chief Strategist at Campos Inc, a market research and strategic planning firm that uses deep consumer insights to construct customer experiences and drive strategy.
A.J. DrexlerCEO & Chief Strategist, CamposBio
Andrew C. von Eschenbach, MDPresident, Samaritan Health Initiatives: Former Commissioner, U.S. Food & Drug Administration
Andrew C. von Eschenbach, M.D. currently serves as President of Samaritan Health Initiatives, Inc. and as an Adjunct Professor at University of Texas MD Anderson Cancer Center. From September of 2005 to January 2009 he served as Commissioner of Food and Drugs where he championed an agenda to modernize the FDA by process improvement of the regulatory pathway for drugs and medical devices and by fostering creative projects, including FDA’s Critical Path Initiative (designed to bring modern tools of science to the product development process); work plans like the FDA’s Food Protection Plan; and most especially the nurturing of the workforce through initiatives, such as an Agency-wide fellowship program and development of a new integrated campus for the Agency in White Oak, Maryland. Under his leadership, the FDA experienced dramatic increases in resources enabling implementation of many new programs designed to strengthen the FDA in its mission to protect and promote public health. He has emphasized FDA’s role in working with external partners to assure quality throughout the entire life cycle of the products it regulates.
Dr. von Eschenbach joined FDA after serving for four years as Director of the National Cancer Institute (NCI) at the National Institutes of Health where he set an ambitious goal to eliminate the suffering and death due to cancer by rapid acceleration and integration of the discovery-development-delivery continuum. While at NCI, he committed resources to ensure the application to oncology of nanotechnology, genomics, proteomics, bioinformatics, and other emerging technologies. At the time of his appointment by President Bush to serve as Director of NCI, he was President-Elect of the American Cancer Society.
Andrew C. von Eschenbach, MDPresident, Samaritan Health Initiatives: Former Commissioner, U.S. Food & Drug AdministrationBio
Peter Fasolo, PhDExecutive Vice President, Chief Human Resources Officer, Johnson & Johnson
Peter M. Fasolo is Executive Vice President, Chief Human Resources Officer, responsible for global talent, recruiting, diversity, compensation, benefits, employee relations and all aspects of the human resources agenda for Johnson & Johnson. Peter first joined Johnson & Johnson in 2004 as Worldwide Vice President, Human Resources for Cordis Corporation. Peter has more than 25 years of global experience in healthcare, having spent 13 years with Bristol-Myers Squibb in executive level, human resource roles in the pharmaceutical, medical devices and consumer segments.
Peter Fasolo, PhDExecutive Vice President, Chief Human Resources Officer, Johnson & JohnsonBio
Patrick GeraghtyCEO, GuideWell and Florida Blue
As CEO of GuideWell and Florida Blue, Pat Geraghty is leading a transformation at the company from a 70+ year old traditional insurance company to a $13 billion leading health solutions company with a strong health, wellness and prevention orientation. GuideWell is the parent to a family of forward-thinking companies focused on transforming health care.
Patrick GeraghtyCEO, GuideWell and Florida BlueBio
Neil GrimmerFounder and CEO, Habit
Neil Grimmer is the founder and CEO of Habit, pioneering personalized nutrition through deep science and food innovation. With a diverse and creative background, Neil was a punk rock musician before moving into product design at IDEO. Now with Habit, he’s building a nutrition platform to help consumers understand the transformative power of food - from test to table.
Having always been one to play with his food, he co-founded Plum Organics, the nation’s leading organic baby food brand, to bring the best, healthy food to kids. Neil sold Plum Organics to Campbell Soup in 2013 and remains active as the chairman of the board.
Today, Neil is on a mission to change the world through food once again, this time for grown-ups. His inspiration for Habit began with his journey as a tri-athlete that hung up his running shoes for a different race - running a company. But after putting the company first and his health last, he found himself 50 pounds overweight and at risk for long-term health issues. After many genetic and blood tests, trips to specialists and nutrition analysis, the idea of Habit was born, making Neil’s health journey accessible to the average consumer. Launched in 2016, Habit is the first personalized nutrition company that is challenging the multi-billion-dollar diet industry, using science to prove that each person requires different nutrients for their own optimal wellbeing.
Neil is a proven business leader, being named Innovator of the Year by Nutrition Business Journal, an Ernst & Young Entrepreneur of the Year and re-incorporating Plum Organics as a Public Benefit Corporation. Neil is also a fellow at the Aspen Institute.
Neil GrimmerFounder and CEO, HabitBio
Sanjay Gupta, MDChief Medical Correspondent, CNN
Sanjay Gupta is a practicing neurosurgeon and the multiple Emmy® award-winning chief medical correspondent for CNN reporting on health and medical news around the world. He is also a staff neurosurgeon at Emory University School of Medicine, associate chief of neurosurgery at Grady Memorial Hospital, contributor to CBS' news magazine, "60 Minutes," and the author of three New York Timesbest-selling books.
Sanjay Gupta, MDChief Medical Correspondent, CNNBio
Matthew HarrisFounding Partner, Global Infrastructure Partners and Founder, Bedari Foundation
Matthew Harris is a founding partner of Global Infrastructure Partners (GIP) and is based in New York. Matthew leads GIP’s global energy industry investment team including crude oil and refined product, natural gas, electricity, LNG, petrochemicals and metals and mining. He is also a member of the Executive Committee of GIP and of its Investment and Portfolio Valuation Committees. Matthew has been intimately involved in GIP’s investment, management and strategic activities since its formation in 2006. He is a member of the Board of Directors of Hess Infrastructure Partners (HIP).
GIP is an independent infrastructure fund manager that combines deep industry expertise and relationships with industrial best practice operational management. GIP was founded in 2006 to invest in high quality infrastructure assets in the energy, transportation and water / waste sectors, each an area in which GIP has a depth of experience and longstanding relationships. GIP manages approximately $40 billion for its investors. Additionally, the companies in GIP’s investment portfolio have combined annual revenues greater than $32.5 billion and employ approximately 48,000 people.
Prior to the formation of GIP in 2006, Matthew was a Managing Director in the Investment Banking Department at Credit Suisse. Most recently, he was Co-Head of the Global Energy Group and Head of the EMEA Emerging Markets Group. Prior to this, Matthew was a senior member of the Mergers and Acquisitions Group and served as Co-Head of Americas Mergers and Acquisitions. Previously, he was a senior member of the Mergers and Acquisitions Group at Kidder Peabody & Co. Incorporated.
Matthew is the Co-Founder and Co-Chairperson of The Bedari Foundation. The Bedari Foundation is a private family foundation dedicated to using its experience and resources to enable significant cultural shifts in the fields of mental health and wellness, community displacement and environmental conservation. The Foundation’s vision is that humanity can cultivate the deeper sense of self-awareness and spirituality required to reassess underlying attitudes, beliefs and responsibilities about ourselves, our communities and our planet. The Bedari Foundation strives to instill the awareness necessary to help solve mental health issues such as addiction, depression and trauma, community displacement issues such as refugees and displaced persons and environmental issues such as depletion of species, global warming and over-consumption. The Foundation champions and encourages a philosophy of interconnected well-being and invests in and supports programs that further these ideals through action and education.
Matthew is co-founder of The Avatar Companies. Avatar is a private partnership focused on making equity investments in the emerging fields of mental health and wellness. Avatar's companies typically offer proprietary, branded and scaleable solutions to the mental health crisis affecting our world. Avatar’s areas of focus include diagnostics, education and training, information management, treatment and support services and technology. Avatar's vision is to develop and nurture a family of companies united in their purpose to eliminate the stigma of mental illness through investment. Having overcome his own struggles with addiction, Matthew believes investment in leading mental health and wellness businesses creates the opportunity to bring about the profound change many of us are seeking in the world today.
Matthew holds a B.A. in Political Science (cum laude) from the University of California at Los Angeles. He is a member of the Board of Directors of the
World Wildlife Fund.
Matthew HarrisFounding Partner, Global Infrastructure Partners and Founder, Bedari FoundationBio
Shannon HartleyChief Marketing Officer, Shatterproof
Shannon Hartley is Shatterproof’s Chief Marketing officer. She leads the teams responsible for delivering the programs and services that support the Shatterproof mission. Her team leads the marketing and educational programs to end the stigma associated with addiction, provides resources to support families and communities focused on preventing addiction and supporting those seeking information on evidence-based treatment and recovery support. Her team leads the program, fundraising and volunteerism activities for Shatterproof. She has more than 20 years of marketing and strategy experience. She began her career at Procter & Gamble in customer insights and sales roles. She led neuroscience/mental health customer insight and global strategy at Bristol-Myers Squibb. Most recently, Shannon was the Managing Director of Razorfish Health, a customer engagement agency that is part of Publicis Healthcare, the largest healthcare marketing and communications network in the world. She is a graduate of Miami University and lives in Princeton, NJ.
Shannon HartleyChief Marketing Officer, ShatterproofBio
Mark Hyman, MDDirector, Cleveland Clinic Center for Functional Medicine
Dr. Hyman believes that everyone deserves a life of vitality and has the potential to create it for themselves. As an educator and practicing physician, he focuses on tackling root causes of chronic disease through Functional Medicine and transforming healthcare. In addition to his work at Cleveland Clinic, he is founder of The UltraWellness Center and Chair of The Institute for Functional Medicine.
Mark Hyman, MDDirector, Cleveland Clinic Center for Functional MedicineBio
Thomas R. lnsel, MDFounder & President, Mindstrong Health; Former Director, NIMH
Thomas R. lnsel, M.D. is a psychiatrist and neuroscientist. From 2002-2015, Dr. Insel served as Director of the National Institute of Mental Health (NIMH), the component of the National Institutes of Health (NIH) committed to research on mental disorders. Most recently he led the Mental Health Team at Verily. Dr. Insel is a member of the National Academy of Medicine and has received numerous national and international awards including honorary degrees in the U.S. and Europe.
Thomas R. lnsel, MDFounder & President, Mindstrong Health; Former Director, NIMHBio
Wayne Jonas, MDExecutive Director, Samueli Integrative Health Programs
Wayne B. Jonas, M.D. is a practicing family physician, an expert in integrative health and health care delivery, and a widely published scientific investigator. Dr. Jonas is the Executive Director of Samueli Integrative Health Programs, an effort supported by Henry and Susan Samueli to increase awareness and access to integrative health. Additionally, Dr. Jonas is a retired Lieutenant Colonel in the Medical Corps of the United States Army. From 2001-2016, he was President and Chief Executive Officer of the Samueli Institute, a non-profit medical research organization supporting the scientific investigation of healing processes in the areas of stress, pain and resilience.
Dr. Jonas was the Director of the Office of Alternative Medicine at the National Institutes of Health (NIH) from 1995-1999, and prior to that served as the Director of the Medical Research Fellowship at the Walter Reed Army Institute of Research. He is a Fellow of the American Academy of Family Physicians.
Wayne Jonas, MDExecutive Director, Samueli Integrative Health ProgramsBio
Mehmood Khan, MDVice Chairman and Chief Scientific Officer, PepsiCo
Mehmood Khan oversees PepsiCo’s global sustainability initiatives and leads PepsiCo’s Global R&D efforts. Prior to joining PepsiCo he was president of Global R&D, for Takeda, Japan’s largest pharmaceutical company. Previously, he was a practicing physician and faculty member at the Mayo Clinic, Hennepin County Medical Center and the University of Minnesota, leading programs in diabetes, endocrinology, metabolism and nutrition.
Mehmood Khan, MDVice Chairman and Chief Scientific Officer, PepsiCoBio
John J.P. Kastelein, MD, PhDProfessor of Medicine, Department of Vascular Medicine, Academic Medical Center of the University of Amsterdam and Strategic Chair of Genetics of Cardiovascular Disease
John J.P. Kastelein (1954) is Professor of Medicine at the Department of Vascular Medicine at the Academic Medical Center (AMC) of the University of Amsterdam, where he holds the Strategic Chair of Genetics of Cardiovascular Disease. Professor Kastelein has published over 850 research papers in peer reviewed journals, including Nature Genetics, Lancet, New England Journal of Medicine, JAMA and Circulation and has a Hirsch index of 102 in March 2017. His citations reached 6100 over 2016 and he is listed among the 3000 Highly Cited Researchers 2014; Dr. Kastelein is on the 10th position for the Netherlands and on the 2nd position for the Unviversity of Amsterdam. He received his medical degree in Amsterdam in 1980 where he subsequently received specialty training in internal medicine. Then, between 1986 and 1988, he was trained in medical genetics, lipidology and molecular biology at the University of British Columbia, Vancouver under the guidance of Prof. Dr. M.R. Hayden.
In 1997 and 1998 he served a visiting Professorship at the Center for Molecular Medicine and Therapeutics at the University of British Columbia, Vancouver, Canada. Upon his return to the Netherlands, he was awarded a doctorate (Cum
Laude) and in 1989 he founded the Lipid Research Clinic at the Academic Medical Center, AMC) in Amsterdam, which is currently serving as a tertiary referral centre and has become part of the department of Vascular Medicine.
The most important concept in Dr. Kastelein’s research career, developed initially at the University of British Columbia, by his mentor Dr. Hayden, and subsequently transformed into practice at the AMC in Amsterdam, the Netherlands, is the “extreme genetics” approach. This approach teaches that the study of rare human disorders that are associated with premature coronary disease have broader relevance for the understanding of the etiology of heart disease in general and will yield therapeutic targets that are valid for all patients.
This approach has been very successful, in so far that Familial Hypercholesterolemia is now internationally recognized as the paradigm for the relationship between LDL-C and heart 3 disease, a relationship substantiated by at least 50 peer reviewed manuscripts and 10 postdoctoral theses in Dr. Kastelein’s curriculum vitae.
John J.P. Kastelein, MD, PhDProfessor of Medicine, Department of Vascular Medicine, Academic Medical Center of the University of Amsterdam and Strategic Chair of Genetics of Cardiovascular DiseaseBio
David Kessler, MDFormer Commissioner, U.S. Food & Drug Administration
Dr. Kessler served as Commissioner of the U.S. Food and Drug Administration under presidents George H. W. Bush and Bill Clinton. He is the author of A Question of Intent and The End of Overeating and Capture: Unraveling the Mystery of Mental Suffering, both New York Times bestsellers. Dr. Kessler is a pediatrician and has been the Dean of the medical schools at Yale and the University of California, San Francisco (UCSF). He is currently a professor of pediatrics and epidemiology and biostatistics at UCSF. Dr. Kessler is a graduate of Amherst College, the University of Chicago Law School, and Harvard Medical School.
David Kessler, MDFormer Commissioner, U.S. Food & Drug AdministrationBio
Mark KingPresident, Adidas North America
As president of Adidas North America, Mark King oversees the business in the U.S. and Canada and is responsible for driving the vision and culture. Mark began his current role in June 2014. Mark is a turnaround expert and has a long and successful track record with the company. He was with TaylorMade for 34 years, beginning his career in the early 1980s as territory sales representative. adidas acquired TaylorMade in 1997 and Mark was elevated to president in 1999 and then CEO in 2002. Under Mark’s leadership from 1999 to 2013, TaylorMade became the leading and most profitable golf company in the world, with sales increasing from $300 million to $1.7 billion.
Mark KingPresident, Adidas North AmericaBio
Robert KnightFounding Director, Center for Microbiome Innovation and Professor of Pediatrics and Computer Science & Engineering at UC San Diego
Rob Knight is the founding Director of the Center for Microbiome Innovation and Professor of Pediatrics and Computer Science & Engineering at UC San Diego. Before that, he was Professor of Chemistry & Biochemistry and Computer Science in the BioFrontiers Institute of the University of Colorado at Boulder, and an HHMI Early Career Scientist. He is a Fellow of the American Association for the Advancement of Science and of the American Academy of Microbiology. He received the 2017 Massry Prize for his microbiome research. In 2015 he received the Vilceck Prize in Creative Promise for the Life Sciences.
Robert KnightFounding Director, Center for Microbiome Innovation and Professor of Pediatrics and Computer Science & Engineering at UC San DiegoBio
Richard E. Lapchick, PhDChair of DeVos Sport Business Management Program and President, The Institute for Sport and Social Justice
Human rights activist, pioneer for racial equality, internationally recognized expert on sports and social issues, scholar and author Richard E. Lapchick is often described as “the racial conscience of sport.” He brought his commitment to equality and his belief that sport can be an effective instrument of positive social change to University of Central Florida where he accepted an endowed chair in August 2001 to launch the DeVos Sports Business Management Program. It has been named one of the nation’s top five programs by the Wall Street Journal, the New York Times and ESPN The Magazine. In 2009 it was named the #1 MBA program in the nation for volunteer service. In 2015 it was named the number 2 program in the world by SportsBusiness International.
Lapchick is a prolific writer. He is working on his 17th book. Lapchick is a regular columnist for ESPN.com and The Sports Business Journal. He has written more than 550 articles and has given more than 2,800 public speeches. He has spoken in the United States Congress, at the United Nations and in the European Parliament.
Under Lapchick’s leadership, the DeVos Program launched The Institute for Diversity and Ethics in Sport (TIDES) in December 2002. TIDES publishes the critically acclaimed Racial and Gender Report Card (RGRC). Lapchick created the RGRC in the late 1980s. It is an annual study of the racial and gender hiring practices of the major professional sports, and college sport in the United States.
Lapchick helped found Northeastern University’s Center for the Study of Sport in Society in 1984 and also helped form the National Consortium for Academics and Sport (NCAS) in 1985. It is a group of over 280 colleges and universities that created the first of its kind degree completion and community service programs. To date, 31,855 athletes have returned to NCAS member schools. Over 14,985 have graduated. Nationally, the NCAS athletes have worked with nearly 19.1 million students in the school outreach and community service program, which focuses on teaching youth how to improve race relations, develop conflict resolution skills, prevent gender violence and avoid drug and alcohol abuse. They have collectively donated more than 20.8 million hours of service while member colleges have donated more than $300 million in tuition assistance. Lapchick helped create National Student-Athlete Day in 1988 which to date has recognized more than 2.6 million high school students for being citizen-scholar- student-athletes.
In December of 2006, Lapchick, his wife and daughter and a group of DeVos students formed the Hope for Stanley Alliance which organizes groups of student-athletes and sports management students to go to New Orleans to work in the reconstruction efforts in the devastated Ninth Ward. As of the summer of 2016, Hope for Stanley members have spent 49 weeks working on rebuilding more than 125 homes. Lapchick was named an honorary citizen by the New Orleans City Council in October 2007. HFS has also worked with Tornado victims in Tuscaloosa, AL in New York with the victims of Hurricane Sandy.
Considered among the nation's experts on sport and social issues, Lapchick has appeared numerous times on Good Morning America, Face The Nation, The Today Show, ABC World News, NBC Nightly News, the CBS Evening News, CNN and ESPN as well as numerous other news broadcasts.
Lapchick has received nine honorary degrees. He was named the Florida Public Citizen of the Year in 2006. He has been the recipient of numerous humanitarian awards including the Lifetime Achievement Award for Work in Civil Rights from the Rev. Jesse Jackson and the Rainbow/Push Coalition in 2009. He was inducted into the Sports Hall of Fame of the Commonwealth Nations in the category of Humanitarian along with Arthur Ashe and Nelson Mandela. Lapchick has won the Arthur Ashe Voice of Conscience Award, the Women’s Sports Foundation Presidents Award, the Ralph Bunche International Peace Award and the Wendell Scott Pioneer Award in 2004 and the NASCAR Diversity Award in 2008 for leadership in advancing people of color in the motor sports industry. He was also inducted into the Central Florida Sports Hall of Fame in 2010 and the Multi-Ethnic Hall of Fame in 2011.
In 2012, Lapchick was honored by the Holocaust Memorial Resource and Education Center of Florida at its annual Dinner of Tribute. He also received the Champions Award from the Alliance of Women’s Coaches, the only male to receive the award in 2012. The Black Coaches Association presented Lapchick with their Distinguished Service Award which was only the 2nd time they presented this award in 28 years. Lapchick received the Mannie Jackson Human Spirit Award at the 2012 Basketball Hall of Fame enshrinement ceremonies.
In August of 2013, he received the Pioneer Award from the National Association of Black Journalists. In 2014, the National Basketball Retired Players Association gave Lapchick, Bill Russell and Pat Summit their Life Achievement Award. Lapchick was inducted into the New York City Basketball Hall of Fame in 2015. He was named as one of Beyond Sports Inspirational 50 people (living and passed) who used sport to change the world along with Billie Jean King, Muhammad Ali, Nelson Mandela and David Stern.
In 2016, he was honored by the Harvard Medical School with the Harvard Impact Global Health Catalyst Distinguished Leader Award for his work in diversity and inclusion.
Shut-Out Trafficking is the NCAS’ effort to combat human trafficking with week-long programs on 10 NCAS campuses each year starting in 2014-15 engaging student-athletes, coaches and athletic administrators to help inform their campuses about this huge issue. It is a partnership with the US Fund for UNICEF. In its first two years it engaged for more 40,000 students, student-athletes, faculty and administrators on those campuses. SOT will be on 10 campuses in 2016-17.
He is listed in Who's Who in America, Who's Who in American Education, Who's Who in Finance and Industry, and Who's Who in American Business. Lapchick was named one of the 100 Most Powerful People in Sports for six years, one of the 20 Most Influential People in College Sport and one of the 20 Most Influential People in Sport in Florida.
Lapchick was one of 200 guests personally invited by Nelson Mandela to his inauguration after leading the American sports boycott of South Africa from 1975 until the end of Apartheid.
Lapchick is a board member of the OnePULSEFoundation, Florida Abolitionist, the Women’s Sports Foundation and the Central Florida YMCA. He is on the advisory boards of the Positive Coaching Alliance, Harbor House, ESPN-W, Champion Women, the SEED Project and the Giving Back Fund. He is a founder of the Hope for Stanley Alliance and the Shut Out Trafficking campaign.
Richard Lapchick is the son of Joe Lapchick, the famous Original Celtic center who became a legendary coach for St. John's and the Knicks. He is married to Ann Pasnak and has three children and four grandchildren.
Richard E. Lapchick, PhDChair of DeVos Sport Business Management Program and President, The Institute for Sport and Social JusticeBio
Governor Michael LeavittFounder, Leavitt Partners; Former Governor of Utah; Former Secretary, U.S. Department of Health and Human Services
Mike Leavitt is the founder of Leavitt Partners where he helps clients navigate the future as they transition to new and better models of care. In previous roles, Mike served in the Cabinet of President George W. Bush (as Administrator of the Environmental Protection Agency and Secretary of Health and Human Services) and as a three-time elected governor of Utah. Mike is a seasoned diplomat, leading U.S. delegations to more than 50 countries. He has conducted negotiations on matters related to health, the environment, and trade.
Governor Michael LeavittFounder, Leavitt Partners; Former Governor of Utah; Former Secretary, U.S. Department of Health and Human ServicesBio
Thom A. Mayer, MD, FACEP, FAAPMedical Director, NFL Players Association
Dr. Thom Mayer is the Medical Director of the NFL Players Association, a position he assumed at the request of Gene Upshaw on the day Korey Stringer, a tackle for the Minnesota Vikings, passed away from heat stroke. The NFLPA had never before had a Medical Director. Under the leadership of current NFLPA Executive Director DeMaurice Smith, Dr. Mayer and his team pioneered a new era in assuring that the health and safety of NFL athletes are protected. He was named one of “The Top 100 Most Important People in the NFL” by USA Today in 2016.
Thom A. Mayer, MD, FACEP, FAAPMedical Director, NFL Players AssociationBio
Mark McClellan, MD, PhDRobert J. Margolis Professor of Business, Medicine, and Health Policy; Director of the Margolis Center for Health Policy at Duke University; Former Commissioner, U.S. Food & Drug Administration
Mark McClellan, MD, PhD, is the Robert J. Margolis Professor of Business, Medicine, and Health Policy, and Director of the Margolis Center for Health Policy at Duke University. He is a physician-economist who focuses on quality and value in health care including payment reform, real-world evidence and more effective drug and device innovation. He is former administrator of the Centers for Medicare & Medicaid Services and former commissioner of the U.S. Food and Drug Administration, where he developed and implemented major reforms in health policy. He was previously Senior Fellow at the Brookings Institution and a faculty member at Stanford University.
Mark McClellan, MD, PhDRobert J. Margolis Professor of Business, Medicine, and Health Policy; Director of the Margolis Center for Health Policy at Duke University; Former Commissioner, U.S. Food & Drug AdministrationBio
Robert McDonaldFormer Secretary, U.S. Department of Veterans Affairs
Robert A. McDonald was nominated by President Obama to serve as the eighth Secretary of Veterans Affairs and was confirmed by the United States Senate on July 29, 2014.
Secretary McDonald led the Department in its ambitious transformational journey to be a world-class service provider and the No. 1 customer-service agency in the Federal government giving Veterans consistent, high-quality experiences. That undertaking began with reinforcing the importance of VA’s inspiring mission to care for those “who shall have borne the battle,” their families, and their survivors, and re-emphasized VA’s commitment to its I-CARE Values of Integrity, Commitment, Advocacy, Respect, and Excellence. The Department’s MyVA transformation strategy was its catalyst for change, for modernizing VA’s culture, processes, and capabilities.
Over the course of Secretary McDonald’s tenure, VA expanded Veteran access by focusing on staffing, space, productivity, and VA Community Care. VA continued driving down the disability claims backlog while positioning the Department for sweeping appeals reform. And VA made substantial progress in bringing an effective end to Veteran homelessness.
Robert McDonaldFormer Secretary, U.S. Department of Veterans AffairsBio
Ashley McEvoyCompany Group Chairman, Consumer Medical Devices, Johnson & Johnson
Ashley McEvoy is Company Group Chairman for Johnson & Johnson Vision and Johnson & Johnson Diabetes Care Companies, and a member of the Management Committee. In her role, she leads two medically directed, consumer-informed businesses within the company’s global medical device segment. The companies, best known for their market-leading ACUVUE® Brand Contact lenses, TECNIS® Family of Intraocular Lenses and ONETOUCH® Diabetes Devices, post annual sales of nearly $6 billion and are fully-integrated operating companies encompassing strategy, innovation, prototyping, clinical trials, sales, marketing, manufacturing, distribution, and business development and, employ more than 12,000 associates around the world.
Ashley’s varied career that spans more than 20 years at J&J has given her a combination of health care, medical device and brand building savvy that make her particularly suited to size up and respond to the challenges inherent in running these hybrid businesses. In four years under Ashley’s leadership, the contact lens platform added $1B in cume sales, an increase of 11% and returned to above-market performance. The Diabetes Care team outperformed competitive composites in 2015 and is growing market share.
Ashley has run four multibillion dollar companies and given birth to five healthy children, demonstrating that you can have a full personal life while rocketing to the top of a Fortune 50 company. As Worldwide President, Ethicon, Inc., she brought dynamic energy to a 100-year-old, $2.5 billion surgical suture business, accelerating sales and doubling net income in 3 years. She also strengthened the company’s capabilities, improving the five-year value of the Company’s new product pipeline by 26 percent. Earlier, Ashley served as President of McNeil Consumer Healthcare where she transformed the company by overseeing the acquisition and integration of Pfizer Consumer Healthcare (the largest acquisition in the history of Johnson & Johnson at that time). During her tenure, McNeil delivered record double-digit sales and income growth, and held leading market share in every product category in which they competed.
Ashley is committed to diversity and inclusion and she has assembled high performing teams, changing the composition of her own leadership team from 10% diverse to 50% diverse. She serves as the executive sponsor of the Open & Out employee resource group which supports the LGBT community globally. Under her leadership, this group has advanced Johnson & Johnson’s goal having its workforce reflect the populations it serves, and created educational materials to improve understanding and create safe, inclusive work environments, and earning accolades from multiple external organizations.
Ashley’s accomplishments have been recognized by numerous business and philanthropic organizations and she was named a “2012 Working Mother of the Year” by Working Mother Magazine. She is an active member of her community, serving as a board member for the CEO Council for Growth, an organization focused on economic growth for the tri-state region and very involved in Pennsylvania Chamber of Commerce activities.
Ashley McEvoyCompany Group Chairman, Consumer Medical Devices, Johnson & JohnsonBio
Anil MenonGlobal President, Smart+Connected Communities, Cisco
isco is now ranked globally as the top technology leader in smart cities and community digital transformation.
As global president of the Cisco Smart+Connected Communities business, Anil Menon drives success by setting the vision and strategy for its Cisco Kinetic for Cities solutions portfolio, for its partner relationships and its investment policies.
Anil has shepherded the Cisco Smart+Connected Communities initiative from a startup within Cisco to a billion dollar business. Anil's career has been forged at the intersection of business innovation and market disruption. Prior to joining Cisco, Anil was corporate vice president of strategy at IBM, where he held several global functional roles ranging from chief marketing and strategy officer for IBM's global hardware business. Anil managed IBM's corporate transition from a hardware brand to a business technology brand and served on IBM's Strategy Team that helped the company’s CEO set overall business and investment strategy.
Prior to being recruited by IBM in 2001, Anil was a successful tenured professor with an extensive international consulting practice with global blue chip companies. He holds two PhDs—in marketing strategy and statistics—and was on the graduate faculty at Emory University's Goizueta Business School in Atlanta, Georgia. His doctoral dissertation was funded by GE and Harvard Business School’s international business think tank, Strategic Planning Council, where Anil later served on the executive council. Sony Corporation also appointed Anil a Sony Business Fellow during the mid-90s.
Anil is active with the World Economic Forum where he co-chaired its Global Agenda Council on the Future of Cities and also participates in its Future of Health global agenda council. He serves on the board of directors for the Center for Customer Insights at the Yale University School of Management and is on the advisory board for the Johns Hopkins University Carey Business School.
Anil resides in Orlando, Fl., but travels extensively worldwide. Anil is married and the proud father of two daughters. He collects 19th century Baluchi carpets and the earliest (1890-1910) Edison cylinder phonographs.
Anil MenonGlobal President, Smart+Connected Communities, CiscoBio
Leena NasserExecutive Director, The Chopra Institute
Leena Nasser specializes in the intersection of neuroscience, cognitive psychology and education. She is the Executive Director of The Chopra Institute, a leading global non-profit startup aiming to build the next wave of preventative health care. Leena is catalyzing a new movement aimed at bringing about a holistic, systemic and innovative approach to the prevention of noncommunicable disease which by 2020 will be responsible for 73% of deaths worldwide.
Leena NasserExecutive Director, The Chopra InstituteBio
Carlos M. Nunez, MDChief Medical Officer, ResMed
As Chief Medical Officer for ResMed, Dr. Nunez leads Medical Affairs, Market Access, Healthcare Economics, Government Affairs and Clinical Science and Innovation for the world's leading provider of solutions for sleep and respiratory care. This global, multidisciplinary team provides the professional and scientific expertise to align the clinical, economic and public policy realities of modern healthcare with the patient-centered mission and business strategy of ResMed. This includes the safety, quality and regulatory efforts that touch every phase of the patient experience and product lifecycle, as well as the evidence generation and early-stage technology development that defines the cutting edge of clinical research, medical science, and advanced data analytics in sleep and respiratory care.
Carlos joined ResMed from Becton, Dickinson and Company (BD) where he was Senior Vice President of Medical Affairs, and led the office of Science, Medicine and Technology for BD’s largest division. Prior to that, Carlos was Chief Medical Officer at CareFusion, where he built and led a global team that provided medical oversight for all of the businesses and functions of the company. From 2000 to 2011 he was the Chief Physician Executive at Picis, Inc., an industry-leading medical informatics company, which became part of the Optum division of UnitedHealth Group. At Picis/Optum Carlos provided medical leadership as well as clinical direction for corporate strategy, marketing, product development, sales, implementation and customer relations for global markets.
Carlos received his Medical Doctor (M.D.) degree from the University of Miami School of Medicine; where he also completed his postgraduate training in anesthesiology, critical care medicine and clinical research. Before beginning his career in the MedTech industry, Carlos was a practicing anesthesiologist, intensivist and hospitalist, director of critical care research, informatics and analytics, and the Duke University educational affiliation at Carolinas Medical Center Northeast.
Carlos M. Nunez, MDChief Medical Officer, ResMedBio
Peder Olofsson, MD, PhDDirector, The Center for Bioelectronic Medicine at the Department of Medicine, Solna Karolinska Institutet
Peder Olofsson leads the Experimental Cardiovascular Medicine group and directs the Center for Bioelectronic Medicine at the Department of Medicine, Karolinska Institutet, Stockholm, Sweden. Olofsson also holds a position as Associate Investigator at the Feinstein Institute for Medical Research, Manhasset, New York, U.S.A. His research focuses on the molecular mechanisms of reflex control of inflammation. The research ultimately aims to make it possible to treat inflammatory disease by targeting specific neural circuits using electrical interfaces.
Peder Olofsson, MD, PhDDirector, The Center for Bioelectronic Medicine at the Department of Medicine, Solna Karolinska InstitutetBio
Clark C. Otley, MDMedical Director, Department of Business Development, Mayo Clinic
Clark C. Otley, MD serves as the Medical Director of the Department of Business Development at Mayo Clinic, which includes the Divisions of Mayo Clinic Ventures and Corporate Business Development. In this capacity, he is responsible for leading technology development and commercialization of Mayo’s intellectual property and for strategic corporate business development activities at Mayo Clinic in direct partnership with Mayo Clinic’s CEO. With over 500 invention disclosures annually and revenue of $66M in 2017, Mayo Clinic Ventures commercializes Mayo Clinic technologies for the benefit of patients worldwide while generating revenue to support clinical practice, research, and education at Mayo Clinic.
Dr. Otley is a practicing dermatologic surgeon in the Department of Dermatology at Mayo Clinic in Rochester, Minnesota, Professor of Dermatology at Mayo Clinic College of Medicine and served as Chair of the Department of Dermatology from 2008-2017. He serves as Vice President of the Destination Medical Center Economic Development Agency Board, was Founding President of the International Transplant Skin Cancer Collaborative, is Vice President of the American Board of Dermatology, and his technology was the basis of a start-up company focused on minimally invasive varicose vein treatment.
Clark C. Otley, MDMedical Director, Department of Business Development, Mayo ClinicBio
Paul OwenChief Executive Officer, OneOme
Paul Owen, Chief Executive Officer (CEO), joined OneOme in August 2015. Paul was previously at Invitae, a hereditary disease diagnostics company, where he was responsible for leading the global commercialization team. Prior to Invitae, Paul served as Vice Chair of Global Business Development for Mayo Clinic and was the leader of Mayo Medical Laboratories’ global commercial team that is one of the world’s largest full service reference labs. In the past he also was in leadership roles at Zimmer and Boston Scientific. Paul received his B.S. in business administration from the University of Wisconsin – Stout.
Paul OwenChief Executive Officer, OneOmeBio
Mehmet Oz, MD, FACSProfessor of Surgery at Columbia University and nine-time Daytime Emmy® Award winner for The Dr. Oz Show
Dr. Oz has won nine Daytime Emmy® Awards for “The Dr. Oz Show” and is Professor of Surgery at Columbia University. His research interests include heart replacement surgery, minimally invasive surgery, alternative medicine and health care policy. He has authored over 400 original publications, book chapters, and eight New York Times Best Selling books, has received numerous patents, and still participates in heart surgery. He also has a newspaper column in 175 markets internationally, and has a bookazine “The Good Life”, which was voted the hottest new publication in 2014 and entered the top ten of all newsstand sales in 2015. He received his undergraduate degree from Harvard University (1982) and obtained a joint MD and MBA (1986) from the University of Pennsylvania School of Medicine and Wharton Business School. He resides in metropolitan New York City area with his wife Lisa and 4 children.
Mehmet Oz, MD, FACSProfessor of Surgery at Columbia University and nine-time Daytime Emmy® Award winner for The Dr. Oz ShowBio
Sandi PetersonGroup Worldwide Chairman, Johnson & Johnson
Sandi leads over two thirds of Johnson & Johnson’s workforce, including the company’s global operating infrastructure, multiple consumer-facing businesses, and key enterprise initiatives designed to spur innovation and accelerate growth. Sandi is at the forefront of Johnson & Johnson’s efforts to transform healthcare using technology and design-thinking to leverage the company’s unique assets in innovative ways to create breakthrough solutions for patients, consumers and providers.
Sandi PetersonGroup Worldwide Chairman, Johnson & JohnsonBio
Jonathan Perlin, MD, PhD, MSHA, MACP, FACMIPresident, Clinical Services & Chief Medical Officer, HCA - Hospital Corporation of America
Dr. Jonathan B. Perlin is President, Clinical Services and Chief Medical Officer of Nashville, Tennessee-based HCA Healthcare. He provides leadership for clinical services and improving performance at HCA’s 171 hospitals and more than 1,000 outpatient surgical, urgent care and other practice units. Current activities include: advancing electronic health records for learning healthcare and continuous improvement; driving value through (big) data science and advanced analytics; and elevating measured clinical performance and patient safety to benchmark levels. His team recently completed the landmark REDUCE MRSA study that demonstrated a 44 percent improvement on known best practices for reducing bloodstream infections.
Jonathan Perlin, MD, PhD, MSHA, MACP, FACMIPresident, Clinical Services & Chief Medical Officer, HCA - Hospital Corporation of AmericaBio
Linda RosenbergPresident & CEO, National Council for Behavioral Health
Linda Rosenberg is a national expert in the financing and delivery of mental health and substance services. Under her leadership, the National Council for Behavioral Health has become our nation’s most effective advocate for behavioral health prevention, early intervention, science-based treatment, and recovery.
Harnessing the voices of the 10 million adults, children, and families served by the National Council’s 2,900 member organizations, Rosenberg helped secure passage of the federal parity law, expanded integrated behavioral and primary care services, introduced Mental Health First Aid in the U.S., and built an array of organizational, clinical and workforce improvement initiatives.
The National Council’s strong support of the Mental Health and Addiction Treatment Excellence Act will result in the first comprehensive effort to establish community accountability for the health of people with mental illnesses and addictions, the consistent utilization of evidence-based practices, and the standardized measurement of outcomes.
Rosenberg was Senior Deputy Commissioner of the New York State Office of Mental Health prior to joining the National Council. She has experience in designing and operating hospitals, community and housing programs, and implemented New York’s first Mental Health Court.
Rosenberg serves on an array of boards of directors including the Cohen’s Veteran’s Network and the Executive Committee of the National Action Alliance for Suicide Prevention.
Linda RosenbergPresident & CEO, National Council for Behavioral HealthBio
Dan Siegel, MDClinical Professor of Psychiatry, UCLA School of Medicine; Founding Co-Director, Mindful Awareness Research Center at UCLA
Dr. Siegel is a clinical professor of psychiatry at the UCLA School of Medicine and the founding co-director of the Mindful Awareness Research Center at UCLA. He is also the Executive Director of the Mindsight Institute which focuses on the development of mindsight, which teaches insight, empathy, and integration in individuals, families and communities. Dr. Siegel has published extensively for both the professional and lay audiences. His four New York Times bestsellers are: Mind: A Journey to the Heart of Being Human, Brainstorm: The Power and Purpose of the Teenage Brain, with Tina Payne Bryson, Ph.D: The Whole-Brain Child, No-Drama Discipline, and the upcoming The Yes Brain (2018).
Dan Siegel, MDClinical Professor of Psychiatry, UCLA School of Medicine; Founding Co-Director, Mindful Awareness Research Center at UCLABio
Gunhild A. Stordalen, MD, PhDFounder and President of the EAT Foundation
Gunhild A. Stordalen is the founder and president of the EAT Foundation. She is a driving force in linking climate, health and sustainability issues to transform the global food system. Gunhild sits on several boards including Nordic Choice Hotel Group, World Economic Forum´s Global Future Council and BT Group´s Committee for Sustainable and Responsible Business. She is a Young Global Leader of the World Economic Forum and was one of 29 leaders selected by United Nations Secretary-General Ban Ki-moon in 2016 to provide inspiration and direction for the Scaling Up Nutrition (SUN) Movement and its mission in eradicating malnutrition. She holds a PhD in pathology/orthopedic surgery.
Gunhild A. Stordalen, MD, PhDFounder and President of the EAT FoundationBio
Marilyn TavennerPresident & CEO, America's Health Insurance Plans
Marilyn Tavenner is President & CEO of America's Health Insurance Plans (AHIP). As President and CEO of AHIP, Marilyn leads the national association that is the unified voice for the evolving health insurance industry. AHIP members provide health and supplemental benefits to 200 million Americans through employer-sponsored coverage, the individual insurance market, and public programs. Prior to joining AHIP in the summer of 2015, Marilyn served as administrator/principal deputy administrator of the Centers for Medicare & Medicaid Services (CMS) from 2010-2015. Prior to her appointment to CMS, she served as Secretary of Health and Human Resources in the cabinet of Governor Tim Kaine from2006-2010.
Marilyn TavennerPresident & CEO, America's Health Insurance PlansBio
Daryl TolSenior Executive Vice President. President/CEO, Florida Hospital & Central Florida Division
Daryl Tol is senior executive vice president for Adventist Health System and president/CEO for Florida Hospital, as well as the Central Florida Division. In this role, he provides executive leadership and oversight of the 16-campus division, which includes the South Region, where flagship Florida Hospital Orlando resides, and the North Region. He previously served as president/CEO for Florida Hospital and Adventist Health System's Central Florida Region. Prior to that, he served as CEO for Florida Hospital Memorial Medical Center and the five Florida Hospitals within Volusia and Flagler counties. Tol earned a master's degree in health administration from Loma Linda University, and a bachelor's degree in business administration from Walla Walla University.
Daryl TolSenior Executive Vice President. President/CEO, Florida Hospital & Central Florida DivisionBio
Nathaniel Watson, MDProfessor of Neurology, University of Washington
Nathaniel Watson, M.D., is Board Certified in sleep medicine and neurology and serves as Director of the Harborview Medical Center Sleep Clinic and co-director of the UW Medicine Sleep Center. He is the former President of the American Academy of Sleep Medicine and American Board of Sleep Medicine. Among Dr. Watson’s diverse research interests is his current focus on the genetic aspects of habitual sleep duration, sleepiness and circadian rhythms and the association between obstructive sleep apnea and cancer.
Nathaniel Watson, MDProfessor of Neurology, University of WashingtonBio
Michelle WilliamsDean of the Faculty, Harvard T.H. Chan School of Public Health
Michelle A. Williams, SM ’88, ScD ’91, is Dean of the Faculty, Harvard T.H. Chan School of Public Health. She is an internationally renowned epidemiologist and public health scientist, an award-winning educator, and a widely recognized academic leader. Prior to becoming Dean, she was Professor and Chair of the Department of Epidemiology at the Harvard Chan School and Program Leader of the Population Health and Health Disparities Research Programs at Harvard’s Clinical and Translational Sciences Center.
Michelle WilliamsDean of the Faculty, Harvard T.H. Chan School of Public HealthBio
Vonda Joy Wright, MD, MSDirector, Performance and Research Initiative for Masters Athletes
Vonda Wright is an orthopaedic surgeon and internationally recognized authority on active aging and mobility. She specializes in sports medicine and is one of only a few female orthopedic surgeons in the USA. Vonda is the founding director of the Performance and Research Initiative for Masters Athletes (PRIMA) and the Medical Director of the UPMC Lemieux Sports Complex.
Vonda Joy Wright, MD, MSDirector, Performance and Research Initiative for Masters AthletesBio